This generic pharmaceutical drug manufacturer has been around for 25 years and not only leads this foreign nation’s domestic market – it is a major player throughout the world, including the United States. This pharmaceutical manufacturer has developed a new drug for diabetes and is awaiting FDA approval. Approval is expected. Estimated market share in the United States will be 26%, earning enormous profits for this foreign based manufacturer.
http://www.sovereignsociety.com/Portals/0/landing/FullPromo_EDSIKB12.html
